Member Exclusive

Limitless starting materials for large-scale manufacture of MSCs – what does the future hold?

Free-to-access Pharmaceutical Bioprocessing editorial on large-scale manufacture of mesenchymal stem cells, written by Kilian Kelly (Cynata Therapeutics, VIC, Australia)

Go to the profile of RegMedNet
Jul 27, 2015

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.


No comments yet.